組織因子通道抑制因子(TFPI)單克隆抗體
Monoclonal Antibody to Tissue Factor Pathway Inhibitor (TFPI)
TFI; EPI; LACI; TFPI1; Lipoprotein-Associated Coagulation Inhibitor; Extrinsic pathway inhibitor
- 編號MAA394Ra23
- 物種Rattus norvegicus (Rat，大鼠) 相同的名稱，不同的物種。
- 來源單抗制備
- 宿主小鼠
- 效價(克隆號)1#
- Ig亞型 IgG1 Kappa
- 純化方式蛋白A + 蛋白G親和純化
- 標記物無標記物
- 免疫原 RPA394Ra01-組織因子通道抑制因子(TFPI)重組蛋白
- 緩沖液成份0.01M 磷酸鹽緩沖液（pH7.4，containing 0.05% Proclin-300，50% glycerol）
- 性狀液體
- 濃度1mg/mL
- 且適物種-
- 應(yīng)用WB; IHC; ICC; IP.
如果抗體需用于流式細胞術(shù)，請參見流式抗體。 - 下載 英文說明書 中文說明書
- 規(guī)格 20μl100μl 200μl 1ml 10ml
- 價格 ¥ 673 ¥ 1571 ¥ 2244 ¥ 5610 ¥ 22440
- 欲了解實際交易價格和更多情況，請與當?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
DAB staining on IHC-P; Sample: Rat Oviduct Tissue; Primary Ab: 10μg/ml Mouse Anti-Rat TFPI Antibody Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody (Catalog: SAA544Mu19)
-
DAB staining on IHC-P;
Sample: Rat Spinal cord Tissue;
Primary Ab: 10μg/ml Mouse Anti-Rat TFPI Antibody
Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody
(Catalog: SAA544Mu19) -
DAB staining on IHC-P;
Sample: Rat Colon Tissue;
Primary Ab: 10μg/ml Mouse Anti-Rat TFPI Antibody
Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody
(Catalog: SAA544Mu19) -
DAB staining on IHC-P;
Sample: Rat Cerebrum Tissue;
Primary Ab: 10μg/ml Mouse Anti-Rat TFPI Antibody
Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody
(Catalog: SAA544Mu19)
-
Western Blot; Sample: Rat Lung lysate Primary Ab: 5μg/ml Mouse Anti-Rat TFPI Antibody Second Ab: 0.2μg/mL?HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody (Catalog: SAA544Mu19)
-
Western Blot; Sample: Lane1: Rat Plasma; Lane2: Hela cell lysate; Lane3: HepG2 cell lysate
Primary Ab: 3μg/ml Mouse Anti-Rat TFPI Antibody
Second Ab: 0.2μg/mL?HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody
(Catalog: SAA544Mu19)
-
通過ISO 9001、ISO 13485質(zhì)量體系認證
特異性
該抗體是針對TFPI的小鼠單克隆抗體。在免疫組織化學(xué)染色和免疫印跡實驗中能識別TFPI。
用法
Western blotting: 0.5-2μg/mL;
Immunohistochemistry: 5-20μg/mL;
Immunocytochemistry: 5-20μg/mL;
Optimal working dilutions must be determined by end user.
儲存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當?shù)臈l件下存儲，損失率低于5%。
贈品
增值服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種：Rattus norvegicus (Rat，大鼠) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| APA394Ra01 | 組織因子通道抑制因子(TFPI)活性蛋白 | Cell?culture;?Activity?Assays. |
| RPA394Ra01 | 組織因子通道抑制因子(TFPI)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAA394Ra01 | 組織因子通道抑制因子(TFPI)多克隆抗體 | WB; IHC; ICC; IP. |
| LAA394Ra81 | 組織因子通道抑制因子(TFPI)多克隆抗體(異硫氰酸熒光素標記) | WB; IHC; ICC; IF. |
| LAA394Ra71 | 組織因子通道抑制因子(TFPI)多克隆抗體(生物素標記) | WB; IHC; ICC. |
| MAA394Ra24 | 組織因子通道抑制因子(TFPI)單克隆抗體 | WB; IHC; ICC; IP. |
| MAA394Ra25 | 組織因子通道抑制因子(TFPI)單克隆抗體 | WB; IHC; ICC; IP. |
| MAA394Ra23 | 組織因子通道抑制因子(TFPI)單克隆抗體 | WB; IHC; ICC; IP. |
| MAA394Ra21 | 組織因子通道抑制因子(TFPI)單克隆抗體 | WB,IHC |
| MAA394Ra22 | 組織因子通道抑制因子(TFPI)單克隆抗體 | WB; IHC; ICC; IP. |
| MAA394Ra26 | 組織因子通道抑制因子(TFPI)單克隆抗體 | WB; IHC; ICC; IP. |
| SEA394Ra | 組織因子通道抑制因子(TFPI)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMA394Ra | 組織因子通道抑制因子(TFPI)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
| KSA394Ra01 | 組織因子通道抑制因子(TFPI)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗法) | Main materials for "Do It (ELISA Kit) Yourself". |
參考文獻
| 雜志 | 參考文獻 |
| South African Journal of Child Health | Tissue factor pathway inhibitor in paediatric patients with nephrotic syndrome [Sajch: 383] |
| the journal of immunology | Cathepsin G in Experimental Tuberculosis: Relevance for Antibacterial Protection and Potential for Immunotherapy [PubMed: 26320257] |
| Molecular Nutrition & Food Research | Trans‐fatty acid promotes thrombus formation in mice by aggravating antithrombogenic endothelial functions via Toll‐like receptors [PubMed: 25546502] |
| Molecular Carcinogenesis | Endothelial cell‐anchored tissue factor pathway inhibitor regulates tumor metastasis to the lung in mice [PubMed: 25945811] |
| Cell?Biology?International | Extracellular?vesicles?from?malignant?effusions?induce?tumor?cell?migration:?inhibitory?effect?ofLMWH?tinzaparin. [pubmed:27435911] |
| International Journal of Infectious Diseases | Kunitz-type protease inhibitor as a vaccine candidate against schistosomiasis mansoni [pubmed:29128645] |
留言咨詢
